Anbio Biotechnology (NNNN) Cash & Equivalents Growth (1y) (2024 - 2025)
Powered by 
Analysis
Anbio Biotechnology (NNNN) Cash & Equivalents Growth (1y) (2024 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | -44.03% |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | -14.70% |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | 207.69% |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | 43.80% |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | -15.85% |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | -18.63% |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | -27.27% |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | -33.96% |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | -18.66% |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn | 242.34% |